<DOC>
	<DOC>NCT01962077</DOC>
	<brief_summary>assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.</brief_summary>
	<brief_title>Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.</brief_title>
	<detailed_description />
	<criteria>1. healthy children 2. with Asymptomatic primary molars with a deep carious lesion; 3. Exposure of a vital pulp by caries; 4. No clinical or radiographic evidence of pulp degeneration, such as excessive bleeding from the root canal, internal root resorption, interradicular and/or periapical bone destruction,swelling, or sinus tract; 5. Ability to perform a leakage free restoration of the teeth using stainless steel crown, or amalgam/resin based restoration.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>pulpotomy</keyword>
	<keyword>MTA</keyword>
	<keyword>primary teeth</keyword>
	<keyword>formocresol</keyword>
</DOC>